Brief: Merit Medical Systems Q3 Adjusted EPS USD 0.86 Vs. IBES Estimate USD 0.8
30/10/2024 20:05
Oct 30 (Reuters) - Merit Medical Systems Q3 revenue USD 339.8 million vs. IBES estimate USD 334.6 million. * Q3 adjusted net income USD 51.2 million vs. IBES estimate USD 44.8 million * Q3 EPS USD 0.48 * Q3 adjusted gross margin 50.9% * Q3 adjusted operating margin 19.2% * outlook FY revenue USD 1,344-1,352 million * outlook FY EPS USD 3.33-3.38
Recent news on Merit Medical Systems
See all newsMerit Medical Systems Inc reports results for the quarter ended March 31 - Earnings Summary
Merit Medical Q2 adjusted EPS beats estimates, raises 2026 outlook
Brief: Merit Medical Systems Q2 Adjusted EPS USD 1.19 Vs. IBES Estimate USD 0.96
Brief: Merit Medical Shareholders Elect Scott R. Ward To Board Of Directors
Merit Medical Q1 adjusted EPS rises on therapeutic, foundational growth